Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential
Episode Details
In a recent episode of the All-In Podcast, host David Friedberg and co-host Chamath Palihapitiya engage with Daniel Ek on his journey in Entrepreneurship. Ek reflects on his early career optimizing Stardoll alongside Mattias Miksche, a venture supported by Index Ventures and Sequoia Capital. Ek then explains how rampant Music Piracy, fueled by platforms like Napster and Kazaa, inspired him and Martin Lorentzon to launch Spotify in Sweden. They convinced the RIAA to embrace streaming as a legal alternative to piracy and the lack of iTunes availability. Shifting to Healthcare, Ek discusses the systemic issues of the US Healthcare System and his new vertically integrated startup, Neko Health, co-founded with Hjalmar Nilsonne. Neko Health exemplifies Vertical Integration and aims to shift medicine towards Preventative Health to combat Chronic Disease. Utilizing Machine Learning and AI in Healthcare, the company collects longitudinal data, pulling inputs from Apple Health and popular Wearables such as Oura, Whoop, and Fitbit. Having proven its model in Sweden and the UK, Neko Health is expanding across the United States, with its first clinic in New York and upcoming locations in Miami and Washington DC. The conversation then explores the broader AI landscape, particularly LLMs. Ek evaluates the dynamic between Open Source AI (including Open-weight models) and Closed source AI, noting historical parallels to closed tech ecosystems like Apple. When debating AI Regulation, Ek argues that policymakers should focus on AI Compute Power and the sheer volume of GPU infrastructure required, rather than restricting open software. Lastly, Ek highlights how Spotify supports Open Standards in the distribution of Podcasts and briefly touches upon his investment firm, Prima Materia.
This episode discusses the evolution of digital platforms, from Spotify's origins in combating music piracy to Daniel Ek's current venture, Neko Health, which aims to revolutionize preventative healthcare through vertical integration and AI. The conversation also touches on the broader AI landscape, including open-source vs. closed-source models and the role of compute power in AI development and regulation.
Portfolio lens: A basket of ideas focused on the intersection of technology, data, and preventative health, with a secondary theme on the practicalities of AI development and regulation.
Generated with gemini-2.5-flash-lite on 10/3/2026, 7:25:36 AM. For research only. Not financial advice.Neko Health - Vertical Integration in Preventative Healthcare
Neko Health's vertically integrated model, leveraging AI and longitudinal data collection, can significantly improve preventative healthcare outcomes and reduce long-term costs by identifying diseases early.
Daniel Ek details Neko Health's approach, which includes building its own facilities, employing clinicians, developing diagnostic equipment, and using AI to analyze data from blood work, imaging, and wearables. The company has demonstrated success in Sweden and the UK and is expanding in the US, with early data showing the discovery of undiagnosed serious medical situations and significant lifestyle improvements in members.
- Neko Health is a vertically integrated healthcare experience from the ground up, building its own facilities, having its own nurses and doctors, building its own diagnostic equipment, and doing everything on the software side.
- The mission is to create the most valuable hour you can invest in your health.
- The experience includes drawing blood (53 markers), a skin rig with over 6,000 high-res images to index moles and lesions, and analysis of heart/blood circulation and grip strength.
- Members get uninterrupted time with a clinician to go through results.
- Around 1% of members have a serious underlying medical situation that is undiagnosed.
- People with the worst health status are improving the most.
- Members have gone from smoking to not smoking and discovered and treated severe underlying illnesses.
- The company has done over 100,000 scans and published three years of data.
- The $499 price point is economically viable due to vertical integration and leads to positive unit economics with profitable clinics.
- Neko Health allows import of Apple Health data from wearables like Oura and Whoop.
- Successful expansion across the United States with new clinic openings.
- Further validation of Neko Health's model through ongoing data publication and clinical trials.
- Increased adoption of preventative health measures by consumers and employers.
- Development of Gen 2 and subsequent iterations of diagnostic infrastructure and capabilities.
- The US healthcare system's complex incentive structures and resistance to change.
- Scalability challenges in replicating the vertically integrated model across diverse US markets.
- High upfront cost of $499, which may still be prohibitive for a significant portion of the population.
- Regulatory hurdles and the long-term payback periods for preventative health investments within the current insurance framework.
- Competition from other preventative health and diagnostic companies.
- Analyze Neko Health's published data on health outcomes and member improvements.
- Investigate the unit economics and profitability of existing Neko Health clinics.
- Track Neko Health's expansion plans and success in new US markets.
- Research the long-term impact of Neko Health's model on healthcare costs and patient outcomes.
- Compare Neko Health's diagnostic capabilities and AI integration with competitors.
AI Compute Power as a Regulatory Focus
Regulating AI development and deployment should focus on controlling access to significant compute power (GPUs) rather than restricting open-source software, as compute is a more tangible and scalable indicator of advanced AI capabilities.
Daniel Ek argues that policymakers often overlook the fundamental resource required for advanced AI development: compute power. He draws a parallel to historical concerns around supercomputers and suggests that the sheer volume of GPUs and the energy consumed are better metrics for assessing potential risks and controlling access to powerful AI models.
- Policymakers should focus on AI compute power and the sheer volume of GPU infrastructure required, rather than restricting open software.
- The amount of compute used can indicate something about the power of a model (e.g., 100,000 GPUs vs. an open-source model on a home PC).
- Historically, access to Cray supercomputers was limited due to their potential for misuse (e.g., designing nuclear weapons, cracking codes).
- Compute power can serve as a roadblock or a defensible metric for advanced AI capabilities.
- The debate around regulating models trained on X number of teraflops was mentioned.
- Increased public and governmental discussion on AI regulation.
- Major AI breakthroughs or incidents that heighten concerns about AI safety and misuse.
- Developments in GPU manufacturing and availability, influencing compute accessibility.
- Geopolitical competition driving nations to secure AI compute resources.
- Difficulty in accurately measuring and monitoring global compute usage.
- Potential for regulatory focus on compute to stifle innovation and competition, especially for smaller players.
- The possibility that open-source models, even with less compute, could still pose significant risks.
- Lobbying efforts from large AI companies that control significant compute resources.
- The challenge of international cooperation on compute-based AI regulation.
- Track legislative proposals and discussions related to AI compute power regulation globally.
- Analyze the market for GPUs and AI-specific hardware, including supply and demand dynamics.
- Research the energy consumption and environmental impact of large-scale AI model training.
- Evaluate the technical feasibility and effectiveness of monitoring compute usage for regulatory purposes.
- Study historical precedents of regulating access to powerful computing resources.
Watchlist
- Neko Health's US expansion progress (clinic openings, patient acquisition).
- Annual data publications from Neko Health on health outcomes.
- Developments in AI regulation, specifically regarding compute power and GPU access.
- Adoption rates of preventative health services like Neko Health.
- Trends in wearable data integration with health diagnostics.
Open Questions
- What is the long-term impact of Neko Health's preventative approach on overall healthcare spending and chronic disease prevalence?
- How will the US insurance industry adapt to or integrate with vertically integrated preventative care models like Neko Health?
- What are the most effective mechanisms for regulating AI compute power without hindering legitimate research and development?
- Can open-source AI models, even with limited compute, pose systemic risks that require different regulatory approaches?
- How will the integration of diverse data sources (wearables, blood work, imaging) impact the accuracy and utility of AI-driven health predictions?
Key Topics & People
Prominent venture capital firm.
Host of the All-In Podcast and venture capitalist.
.jpg?width=300){kind=avatar}
Host of the All-In Podcast, venture capitalist, and early Facebook executive.
A Swedish entrepreneur who recruited Daniel Ek to help build and scale Stardoll.
A venture capital firm that invested in Stardoll and helped rebrand it.
.png?width=300){kind=avatar}
The illegal downloading of music, which heavily impacted the recording industry and sparked the creation of Spotify.
Co-founder of Spotify who brainstormed the idea with Daniel Ek.
Co-founder and CEO of Neko Health, leading the company's daily operations (transcribed contextually as 'Yael Mar').
A health technology company co-founded by Daniel Ek focusing on proactive, data-driven preventative care.
A proactive approach to medicine aiming to identify and treat diseases early.
Apple's health informatics application, which Neko Health allows users to import data from.
AI models where the weights (parameters) are freely available, reducing costs and preventing tech monopolies.
An investment firm started by Daniel Ek to fund deep technology and support ambitious founders.
Non-proprietary technological guidelines that allow interoperability, which Spotify supports in podcasting.
The physical processing power required to train AI models, proposed as a natural regulatory choke point.
The debate around how to safely govern and restrict AI systems, potentially focusing on compute.
Proprietary AI models heavily controlled by their creators, existing alongside open models.
AI models with accessible source code, which Ek advocates for to drive innovation.
Another target city for Neko Health's rapid US expansion.
.jpg?width=300){kind=avatar}
A major market for Spotify and Neko Health, noted for its complex and highly expensive healthcare system.
The application of artificial intelligence to analyze patient data, track skin lesions, and improve health outcomes.
Algorithms utilized to analyze vast datasets for making medical predictions and uncovering insights.
Long-term health conditions that are a major driver of healthcare costs and can often be prevented if caught early.
The complex and expensive medical system in the United States, currently oriented towards reactive care.
A business strategy utilized by Neko Health to control the entire patient experience, from clinics to software.
A massive industry and expense in the US economy, which Neko Health aims to innovate.
The journey and challenges of building startups, which Daniel Ek discusses regarding Spotify and Neko Health.
_(cropped).jpg?width=300){kind=avatar}
A popular technology and business podcast where industry leaders discuss startups, economy, and global events.